Afatinib Plus Bevacizumab Combination After Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR -Mutant Non-Small Cell Lung Cancer: Multicenter, Single-Arm, Phase 2 Trial (ABC Study)
Cancer - United States
doi 10.1002/cncr.31678
Full Text
Open PDFAbstract
Available in full text
Date
September 7, 2018
Authors
Publisher
Wiley